The company focuses on creating innovative solutions for various diseases by using purified microbiota and bacterial consortia from healthy donors. Their product pipeline includes treatments for Autism Spectrum Disorder, Crohn's disease, Atopic Dermatitis, longevity, and sports performance. Additionally, Microviable Therapeutics specializes in microbiota kits that preserve and store intestinal microbiota samples, enabling healthcare professionals to collect and transport samples without the need for freezing. Their goal is to develop biotherapeutics based on complex communities from the intestinal microbiota to address microbiota dysbiosis in certain diseases.